New Vistas in GPCR Research: the Dawn of an Exciting Drug Discovery Era?
Annual One-Day Meeting on Medicinal Chemistry of SRC & KVCV
Braine-L'Alleud, Belgium November 21, 2014
Registration
Opening
L01 - GPCR-ligand Structures through the Looking Glass: Computer-Aided Prediction of GPCR-Ligand Interactions
L02 - Nanobodies to Study GPCR Transmembrane Signaling: From Structures to Function to Drugs
Coffee Break
OC01 - Discovery of Donecopride: Design of Dual 5-HT4R Agonists/AChE Inhibitors Multi-Target Directed Ligands for Alzheimer's Disease Treatment
L03 - Dual A2A-NR2B Antagonists: Potential for Unprecedented Activity in Parkinson’s Disease
Sandwich Lunch
L04 - Biased Ligands, Allosteric Modulation: New Technological Approaches
OC02 - Novel Histamine H1-Receptor Fluorescent Antagonists for the Study of Receptor-Ligand Interactions
OC03 - Identification of Modulators for SUCNR1 BY Screening of a SOSA Library with a Bioluminescent cAMP Assay
Coffee Break and Poster Session
L05 - Developing Ligands to Validate the Role of Receptors for Long-chain Fatty Acids in the Treatment of Type II Diabetes
L06 - Positive Allosteric Modulators of mGlu2 Receptors for the Treatment of CNS Disorders
Closing Remarks